Imperative Care begins CLEAR-IT study as peripheral thrombectomy moves from device adoption to evidence scrutiny
Imperative Care’s CLEAR-IT study could reshape peripheral thrombectomy standards. Read why its real-world data strategy matters now.
What Toro Neurovascular’s FDA-cleared Toro 88 catheter means for the neurovascular device market
FDA clears Toro Neurovascular’s Toro 88 catheter for stroke intervention. Discover how this device could reshape neurovascular access and aspiration thrombectomy.